Immune Thrombocytopenia in Children

Authors

  • D.M. Voda Children’s Hospital of Brasov, Romania
  • I. Luca Transilvania University of Brasov, Romania

DOI:

https://doi.org/10.31926/but.ms.2023.65.16.2.4

Keywords:

Idiopathic thrombocytopenic purpura, COVID-19, SARS-CoV-2, immune thrombocytopenia

Abstract

Immune thrombocytopenia is a hematological disorder defined by an isolated decrease in platelet numbers. We present a retrospective-descriptive study that enrolls twenty-five children (aged 0-18 years old) admitted to Brasov Children’s Hospital from the 1st of January 2020 until the 1st of September 2023 with the diagnosis of idiopathic thrombocytopenic purpura (ITP). We could find proof of recent viral infection in seven patients out of twenty-five; three of them also had immunological findings- positive antinuclear, positive direct Coombs test, or antiplatelet antibodies. The medical literature mentions glucocorticoids and IVIG therapy as the first line of treatment for immune thrombocytopenic purpura, while new pharmaceutical agents are still under review.

Author Biography

I. Luca, Transilvania University of Brasov, Romania

Faculty of Medicine

Downloads

Published

2024-01-19

Issue

Section

MEDICAL SCIENCES